GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Lotus Bio-Technology Development LBTD · USD

N/A · US listing · 🇺🇸 United States

Compare

0.01

—

Close of 30 Oct 2026, in USD

About Lotus Bio-Technology Development

Its shares trade under the ticker LBTD. It has been listed since 14 March 2013.

Lotus Bio-Technology Development Corp. refines organic materials to produce natural consumer products. The firm focuses on specializing in the refining of organic materials and the production of natural consumer related products. The company is exploring opportunities in the organic growth and farming sector in China. The firm's operations are organizational matters, planning its Websites and developing its business plan. The firm is in start-up stage and has not generated any revenues.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
N/A
Industry
N/A
Listed since
14 Mar 2013

Leadership

Pay as last reported

  • Mr. Zoltan NagyPresident, Chief Executive Officer, Director, since 2011

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Lotus Bio-Technology Development Corp refines organic materials to produce natural consumer products.
  • The firm specializes in the refining of organic materials for its business.
  • The company is exploring opportunities in the organic growth and farming sector.

Weaknesses

  • The firm is in start-up stage and has not generated any revenues.
  • Operations are currently focused on organizational matters and planning its Websites.
  • The firm is developing its business plan rather than generating income.

Opportunities

  • The company is exploring opportunities in the organic growth and farming sector.
  • Lotus Bio-Technology Development Corp can expand its natural consumer product lines.
  • The firm may leverage its organic material refining capabilities for new markets.

Threats

  • The firm is in start-up stage and has not generated any revenues.
  • Lotus Bio-Technology Development Corp faces risks due to its early operational phase.
  • The company relies on developing its business plan for future stability.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.